- Home
- SERV vs LYEL Comparison
SERV vs LYEL Comparison
Compare SERV & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SERV | LYEL |
|---|---|---|
| Founded | 2017 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 724.7M | 745.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SERV | LYEL |
|---|---|---|
| Price | $10.33 | $30.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $18.20 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 7.7M | 117.8K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,944,483.00 | $41,000.00 |
| Revenue This Year | $44.11 | N/A |
| Revenue Next Year | $891.96 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.76 | N/A |
| 52 Week Low | $4.66 | $7.65 |
| 52 Week High | $24.35 | $45.00 |
Technical Indicators
Market Signals| Indicator | SERV | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 51.49 |
| Support Level | $9.77 | $32.01 |
| Resistance Level | $11.22 | $45.00 |
| Average True Range (ATR) | 0.80 | 3.42 |
| MACD | -0.10 | -0.65 |
| Stochastic Oscillator | 20.19 | 3.20 |
Price Performance
Historical ComparisonAbout SERV Serve Robotics Inc.
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.